How prostate cancer treatments cause cell aging: causes, treatment options, and patient impacts

Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Joaquin Mateo reports a relationship with AstraZeneca that includes: consulting or advisory and funding grants. Joaquin Mateo reports a relationship with Amunix-Sanofi that includes: consulting or advisory. Joaquin Mateo reports a relationship with Daichii-Sankyo that includes: consulting or advisory. Joaquin Mateo reports a relationship with Janssen that includes: consulting or advisory. Joaquin Mateo reports a relationship with MSD that includes: consulting or advisory. Joaquin Mateo reports a relationship with Pfizer that includes: consulting or advisory and funding grants. Joaquin Mateo reports a relationship with Roche that includes: consulting or advisory. Joaquin Mateo reports a relationship with Nuage Therapeutics that includes: consulting or advisory. Joaquin Mateo reports a relationship with Amgen that includes: funding grants. David P. Labbé serves as an Associate Editor for Gene. The other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.